Antineoplastic Agents
Antineoplastic Agents Companies (22)
Antineoplastic Agents Products (97)
-
Product Goserelin Acetate PFS 3.6 mg
Description: Sterile depot formulation of goserelin acetate supplied in a pre-filled syringe for subcutaneous implantation. It is a long-acting gonadotropin-releasing hormone (GnRH) agonist designed for sustained suppression of sex hormone production with extended-release dosing, typically administered on...
-
Product Neutromax 30 M I.U./ 48 M I.U.
Filgrastim is a recombinant methionyl human granulocyte colony stimulating factor (r-Met-Hu-GCSF), produced by bacterial fermentation. Filgrastim is used to treat neutropenia, a side effect of chemotherapy, which makes patients more susceptible to bacterial infections.
Biosidus Filgrastim product is av...
-
Product Oxaliplatin SEDICO vials
Treat certain cancers, especially colorectal (colon and rectal) cancer.
-
Product Lomustine
Product Name: Lomustine
CAS:13010-47-4
Molecular Formula: C9H16ClN3O2
Molecular Weight: 233.7
Properties: Yellow, crystalline powder
...
-
Product Bortezomib
Carelife offers a wide range of products which includes Clindamycin Hydrochloride, Phosphate, Palmitate Hydrochloride.
We also offer:
Iron sucrose
Ferric carboxymaltose
Pemetrexed disodium
Granisetron HCl
Mitoxantrone HCl...
-
Product Flupentixol Dihydrochloride BP/EP
Flupentixol Dihydrochloride is an antipsychotic medication belonging to the thioxanthene class. It is primarily used to treat schizophrenia and other mental health disorders, including depression.
Mechanism of Action:
Alters the balance of neurotransmitters in the brain, parti...
-
Product Amifostine for Injection
Chemotherapy: used prior to chemotherapy in patients with various cancers, including lung cancer, ovarian cancer, breast cancer, nasopharyngeal carcinoma, bone tumors, gastrointestinal tumors, and hematological malignancies, to significantly ease the toxic effects of chemotherapeutic agents on the kidneys,...
-
Product ANTI CANCER INJECTABLES PEMETREXED
Pemetrexed for Injection is a folate-dependent antineoplastic agent that disrupts folate-dependent metabolic processes essential for cell replication. It is used in the treatment of malignant pleural mesothelioma and non-small cell lung cancer.
Pack Strengths Available: 100 mg, 500 mg
qq...
-
Product Leuprorelin Acetate
Treatment of endometriosis, uterine fibroids, prostate cancer, and central precocious puberty.
-
Product Enlength
As a cornerstone drug for the treatment of multiple myeloma, Bortezomib is used throughout the induction, consolidation and maintenance therapies for myeloma. In 2020, Bortezomib was recommended as a first-line drug for the full management of multiple myeloma in the Guidelines for Diagnosis and Treatm...
-
Product Hydrobromic Acid in Acetic Acid
It is mainly used in the industries of pharmaceuticals, pesticides, etc. In the field of medicine, it is used for synthesizing sedatives and anesthetics, and can also be applied in the petroleum industry, as well as in the production of synthetic dyes and fragrances.
-
Product Finished formulation for General products and Oncology products
Finished formulation for General products and Oncology products
Formulations available in
-- Tablets
-- Capsules
-- Dry powder for suspension
Products packed in
-- Blister pack
-- Drum pack
-- Bottle Pack
-- Sachet
-
Product Fludarabine Phospate
Manufactured in OEB5 workshop which has passed FDA on-site audits for three times.US DMF and EU CEP are all available.
Could support in registration APIs in all countries.
-
Product Enzalutamide Soft Capsules
Suitable for metastatic resistance to prostate cancer (CRPC). After the failure of androgen deprivation of therapy (ADT), Enzalutamide can delay the progress of the disease by inhibiting the inhibitors of therogen receptor signaling pathway and improve the quality of life of patients.
Upcoming Events
-
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026 -
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026


